LIGAND PHARM Probability of Target Price Finishing Over Current Price

    LGNZZ -- USA Stock  

    USD 0.12  0.00  0.00%

    LIGAND PHARM probability of target price tool provides mechanism to make assumptions about upside and downside potential of LIGAND PHARM INC performance during a given time horizon utilizing its historical volatility. Please specify LIGAND PHARM time horizon, a valid symbol (red box) and a target price (blue box) you would like LIGAND PHARM odds to be computed. Please see also Stocks Correlation.
    Horizon     30 Days    Login   to change
    Refresh Odds

    LIGAND PHARM Target Price Odds to finish over

    Current PriceHorizonTarget PriceOdds to move above current price in 30 days
     0.12 30 days 0.12  ABOUT 9.66%
    Based on normal probability distribution, the odds of LIGAND PHARM to move above current price in 30 days from now is about 9.66% (This LIGAND PHARM INC probability density function shows the probability of LIGAND PHARM Stock to fall within a particular range of prices over 30 days) .
    Assuming 30 trading days horizon, LIGAND PHARM INC has beta of -0.032 indicating as returns on benchmark increase, returns on holding LIGAND PHARM are expected to decrease at a much smaller rate. During bear market, however, LIGAND PHARM INC is likely to outperform the market. Moreover The company has an alpha of 1.5214 implying that it can potentially generate 1.5214% excess return over DOW after adjusting for the inherited market risk (beta).
     LIGAND PHARM Price Density 
    Alpha over DOW
    Beta against DOW=0.03
    Overall volatility
    Information ratio =0.19


    LIGAND PHARM Alerts and Suggestions

    LIGAND PHARM INC is not yet fully synchronised with the market data
    LIGAND PHARM INC has some characteristics of a very speculative penny stock

    Price Density Drivers

    LIGAND PHARM Health Indicators

    Average Daily Volume Last 10 Day39.59k
    Average Daily Volume In Three Month24.83k
    Please see also Stocks Correlation. Please also try CEO Directory module to screen ceos from public companies around the world.